Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | CASP3 | P42574 | 3/20 | 0.55 |
| ▸ | SENP8 | Q96LD8 | 3/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.55 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP12 | P39900 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14566648 | 0.88 | RAB9A (0.51) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL9815841 | 0.88 | L3MBTL1 (0.57) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL11581518 | 0.86 | L3MBTL1 (0.55) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL4374949 | 0.86 | L3MBTL1 (0.59) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL140814 | 0.86 | ALDH1A1 (0.57) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL3192708 | 0.86 | IDO1 (0.50) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL286760 | 0.84 | IDO1 (0.57) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL2659085 | 0.84 | RAB9A (0.57) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL28837976 | 0.84 | L3MBTL1 (0.54) | L3MBTL1RAB9AMAPTCASP3SENP8 | |
| SCHEMBL9375354 | 0.84 | L3MBTL1 (0.54) | L3MBTL1RAB9AMAPTCASP3SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024191025-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS | 한국콜마주식회사 | 2024-09-19 | — | — | WO | claimed |
| WO-2016151508-A1 | METHOD AND APPARATUS FOR THE PRODUCTION OF DIARYL CARBONATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-09-29 | — | — | WO | claimed |
| CN-114787139-B | Methods and intermediates for preparing MCL1 inhibitors | 吉利德科学公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250051259-A1 | METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-13 | — | — | US | disclosed |
| CN-114621222-B | 6-6 Fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-20240400496-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-05 | — | — | US | disclosed |
| WO-2024191025-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS | 한국콜마주식회사 | 2024-09-19 | — | — | WO | disclosed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | disclosed |
| EP-4421063-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-28 | — | — | EP | disclosed |
| EP-4414357-A1 | METHOD FOR PRODUCING HIGH-PURITY DIARYL CARBONATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-14 | — | — | EP | disclosed |
| CN-110573511-B | 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2023-04-25 | — | — | CN | disclosed |
| EP-0855384-A1 | PROCESS FOR THE PREPARATION OF AROMATIC CARBONATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-07-29 | — | — | EP | disclosed |
| US-5760156-A | Manufacturing method for polycarbonate | GENERAL ELECTRIC COMPANY (US) | 1998-06-02 | — | — | US | disclosed |
| US-5747609-A | REACTION OF DIALKYL CARBONATE WITH PHENOL IN THE PRESENCE OF CATALYST TO PRODUCE DIPHENYL CARBONATE, POLYMERIZATION WITH PHENYLDIHYDROXY COMPOUND FOR AROMATIC POLYCARBONATE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1998-05-05 | — | — | US | disclosed |
| EP-0781760-A1 | Continuous manufacturing method for aromatic carbonates | GENERAL ELECTRIC COMPANY (US) | 1997-07-02 | — | — | EP | disclosed |
| EP-0780361-A1 | Manufacturing method for aromatic carbonates | GENERAL ELECTRIC COMPANY (US) | 1997-06-25 | — | — | EP | disclosed |
| EP-0779312-A2 | Manufacturing method for polycarbonate | GENERAL ELECTRIC COMPANY (US) | 1997-06-18 | — | — | EP | disclosed |
| EP-0461274-B1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | ASAHI CHEMICAL IND (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5210268-A | Ester interchange, catalysis | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0461274-A1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051259-A1 | METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE | CA9, CA3, CEL | L3MBTL1 4139/4885RAB9A 1573/4885MAPT 3397/4885 |
| US-20240400496-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | HBB, HBG2, HBG1 | L3MBTL1 4243/4885RAB9A 4389/4885MAPT 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.